Related Experiment Video
Updated: May 29, 2025

14:57
Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
94.0K
A central role for acetylcholine in entorhinal cortex function and dysfunction with age in humans and mice
Mala R Ananth1, John D Gardus2, Chuan Huang3
1National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, USA.
Cell Reports
|February 1, 2025
Summary
Cholinergic system decline in the entorhinal cortex (EC) is an early sign of cognitive aging in humans and mice. This loss impacts EC function and may predict cognitive status.
Area of Science:
- Neuroscience
- Aging Research
- Cognitive Science
Background:
- Structural and functional changes in the entorhinal cortex (EC) are early indicators of cognitive aging.
- The role of the cholinergic system in early EC impairments and cognition is not fully understood.
Purpose of the Study:
- To investigate the relationship between cholinergic input integrity and cognitive deficits in aging humans and mice.
- To determine if compromised cholinergic systems are a primary driver of early entorhinal cortex impairments.
Main Methods:
- Utilized in vivo imaging techniques including Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) in older humans.
- Employed high-resolution imaging in wild-type mice and mice genetically susceptible to Alzheimer's disease pathology.
- Conducted mechanistic studies in mice to assess the role of EC-projecting cholinergic neurons in behavior.
Main Results:
- Loss of cholinergic input to the entorhinal cortex (EC) is an early feature of cognitive aging, observed in both humans and mice.
- Mechanistic studies in mice revealed a central role for EC-projecting cholinergic neurons in EC-related behaviors.
- Alterations in the cholinergic EC are conserved across species and appear early in the aging process.
Conclusions:
- Compromised cholinergic input to the entorhinal cortex (EC) is an early and conserved feature of cognitive aging.
- Loss of cholinergic integrity in the EC may serve as an early predictor of cognitive status.
- Targeting the cholinergic system in the EC could be a potential strategy for mitigating age-related cognitive decline.
Related Concept Videos
Alzheimer's Disease: Overview
437
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
437
Role of Neurotransmitters in Memory
399
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
399
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95

